Gabapentin Tablet, Film Coated
Product Images NDC 71335-1041

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This is a formula used to calculate the creatinine clearance rate of a patient, which is an important measure of kidney function. The formula takes into account the patient's age, weight, and serum creatinine level. It also includes an adjustment factor for female patients. The resulting value can help healthcare professionals determine if a patient has any kidney dysfunction, and adjust medication dosages accordingly.*

FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

This appears to be a list of molecular formulas for organic compounds. The first formula, CH,NH, is not a valid molecular formula as it is missing information about the number of atoms. The second formula, CH,CO,H, represents acetic acid, a colorless liquid widely used in the production of a variety of industrial and consumer goods.*

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

This appears to be a table showing the mean pain score for a fixed dose period of 4 weeks, comparing a placebo group to two groups taking different doses of Gabapentin (1800mg/day and 2400mg/day). The pain score was recorded at baseline and at various time points during the 4-week period.*

FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

The text includes a figure 3 showing the proportion of responders in controlled PHN studies with patients having more than a 50% reduction in pain score. There are two studies mentioned, Study 1 and Study 2. However, the percentages of responders in Study 1 are not provided. The figure also has some statistical markers such as "p < 0.001" and "#p< 00l" denoting significant differences in data. Lastly, the text includes the names of some drugs and their costs.*

FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

FDA Label Image

Label Image (Lbl713351041)

This appears to be a label of a medication, possibly a generic version of Neurontin 800mg tablet, produced by Strides Pharma Science Limited. The medication is packaged by Bryant Ranck Prepack and expires at a certain month and year (MM/YY) as indicated on the label. The NDC (National Drug Code) number is also provided for identification. The storage condition for the medication is between 20°-25°C, with instructions to keep all drugs out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.